Literature DB >> 29289644

Matrix metalloproteinases and liver fibrosis (translational aspects).

Elke Roeb1.   

Abstract

Liver fibrosis, a reversible wound-healing response to chronic cellular injury, reflects a balance between liver repair and progressive substitution of the liver parenchyma by scar tissue. Complex mechanisms that underlie liver fibrogenesis are summarized to provide the basis for generating targeted therapies to reverse fibrogenesis and improve the outcomes of patients with chronic liver disease. This minireview presents some pathophysiological aspects of liver fibrosis as a dynamic process and elucidates matrix metalloproteinases (MMPs) and their role within as well as beyond matrix degradation. Open questions remain, whether inhibition of fibrogenesis or induction of fibrolysis is the key mechanism to resolve fibrosis. And a point of principle might be whether regeneration of liver cirrhosis is possible. Will we ever cure fibrosis?
Copyright © 2018 The Author. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Fibrosis; Hepatic stellate cells; Liver; MMPs; Proteases; TIMP

Mesh:

Substances:

Year:  2017        PMID: 29289644     DOI: 10.1016/j.matbio.2017.12.012

Source DB:  PubMed          Journal:  Matrix Biol        ISSN: 0945-053X            Impact factor:   11.583


  39 in total

1.  Hepatoprotective effect and possible mechanism of phytoestrogen calycosin on carbon tetrachloride-induced liver fibrosis in mice.

Authors:  Mengmeng Zhang; Yaxin Wang; Guannan Zhu; Cheng Sun; Jiajia Wang
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2020-05-30       Impact factor: 3.000

2.  The Role of Tissue Inhibitor of Metalloproteinase-1 and 2 in Echinococcus granulosus senso lato-Induced Human Hepatic Fibrosis.

Authors:  Azadeh Hasanzadeh; Abdollah Rafiei; Mohammad Kazemi; Molouk Beiromvand; Amin Bahreini; Hossein Khanahmad
Journal:  Acta Parasitol       Date:  2022-03-16       Impact factor: 1.440

3.  Pantoprazole ameliorates liver fibrosis and suppresses hepatic stellate cell activation in bile duct ligation rats by promoting YAP degradation.

Authors:  Zhen-Ning Lu; Wei-Xiao Niu; Na Zhang; Mao-Xu Ge; Yun-Yang Bao; Yu Ren; Xiu-Li Guo; Hong-Wei He
Journal:  Acta Pharmacol Sin       Date:  2021-08-31       Impact factor: 6.150

4.  Serum matrix metalloproteinase-7 levels in infants with cholestasis and biliary atresia.

Authors:  Pejman Rohani; Seyyed Bahador Mirrahimi; Haleh Bashirirad; Parisa Rahmani; Niyoosha Kamran; Hosein Alimadadi; Mahmoud Hajipour; Mohammad Hassan Sohouli
Journal:  BMC Pediatr       Date:  2022-06-18       Impact factor: 2.567

Review 5.  Molecular pathways of nonalcoholic fatty liver disease development and progression.

Authors:  Fernando Bessone; María Valeria Razori; Marcelo G Roma
Journal:  Cell Mol Life Sci       Date:  2018-10-20       Impact factor: 9.261

Review 6.  Neovascularization is a key feature of liver fibrosis progression: anti-angiogenesis as an innovative way of liver fibrosis treatment.

Authors:  Mariia Zadorozhna; Sante Di Gioia; Massimo Conese; Domenica Mangieri
Journal:  Mol Biol Rep       Date:  2020-02-10       Impact factor: 2.316

7.  TAF and TDF attenuate liver fibrosis through NS5ATP9, TGFβ1/Smad3, and NF-κB/NLRP3 inflammasome signaling pathways.

Authors:  Jing Zhao; Ming Han; Li Zhou; Pu Liang; Yun Wang; Shenghu Feng; Hongping Lu; Xiaoxue Yuan; Kai Han; Xiaofan Chen; Shunai Liu; Jun Cheng
Journal:  Hepatol Int       Date:  2019-11-22       Impact factor: 6.047

8.  Role of necroptosis in chronic hepatic inflammation and fibrosis in a mouse model of increased oxidative stress.

Authors:  Sabira Mohammed; Evan H Nicklas; Nidheesh Thadathil; Ramasamy Selvarani; Gordon H Royce; Michael Kinter; Arlan Richardson; Sathyaseelan S Deepa
Journal:  Free Radic Biol Med       Date:  2021-01-09       Impact factor: 7.376

Review 9.  Alcohol-Related Liver Disease: Basic Mechanisms and Clinical Perspectives.

Authors:  Szu-Yi Liu; I-Ting Tsai; Yin-Chou Hsu
Journal:  Int J Mol Sci       Date:  2021-05-13       Impact factor: 5.923

Review 10.  Fibrotic Events in the Progression of Cholestatic Liver Disease.

Authors:  Hanghang Wu; Chaobo Chen; Siham Ziani; Leonard J Nelson; Matías A Ávila; Yulia A Nevzorova; Francisco Javier Cubero
Journal:  Cells       Date:  2021-05-05       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.